News Releases


Jul 29, 2002

Insmed Incorporated and Avecia Limited Announce Development and Manufacturing Agreement for SomatoKine

Jul 26, 2002

Insmed Incorporated Reports Second Quarter Results

Jul 25, 2002

Insmed Incorporated Invites You to Join Its 2nd Quarter Earnings Conference Call On: Tuesday, July 30, 2002 at 9:00 a.m. EDT

Jul 18, 2002

Insmed Presents Lead Drug Candidates At ENDO 2002, The 84th Annual Meeting of the Endocrine Society

Jul 17, 2002

Insmed Incorporated Receives Orphan Drug Designation for SomatoKine for the Treatment of Growth Hormone Insensitivity Syndrome -Laron Syndrome- and Inititates Clinical Study

Jul 8, 2002

Insmed Incorporated Announces Investor Update Conference Call; Tuesday, July 9, 2002, at 9:00 a.m. ET - 8:00 a.m. CT

Jun 17, 2002

Insmed Reports Data On Insulin Sensitizing Drug At American Diabetes Associations Annual Meeting

Jun 13, 2002

Insmed Announces That Data At American Diabetes Association Annual Meeting Will Highlight Drug Pipeline

May 2, 2002

Insmed Incorporated Reports First Quarter Results

Apr 26, 2002

Insmed Incorporated to Webcast First Quarter Investor Update Conference Call; Friday, May 03, 2002, at 8:00 a.m. ET